Insider · CIK 0001335111
Mark W Begor
ceoofficerdirector
Files at EFX (EQUIFAX INC), RJF (RAYMOND JAMES FINANCIAL INC), NATL (NCR Atleos Corp). First filing Oct 29, 2024, latest Feb 12, 2026.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 6
$0 bought, $58M sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
EFX: EQUIFAX INC
EFXOct 9, 2026 · close 145.78
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 35Weak | EQUIFAX INC | $7.6M 37,791 shares | -14% | +16% from low-27% from high | |
| 33Weak | EQUIFAX INC | $11M 49,345 shares | -29% | +12% from low-18% from high | |
| 25Weak | EQUIFAX INC | $12M 48,264 shares | -25% | +17% from low-21% from high | |
| 28Weak | EQUIFAX INC | $5.7M 22,160 shares | -13% | +25% from low-16% from high | |
| 35Weak | EQUIFAX INC | $5.6M 22,161 shares | -13% | - | |
| 33Weak | EQUIFAX INC | $16M 58,304 shares | -35% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 25, 2026 | EFX EQUIFAX INC | AGrant or award Common Stock | +40,955 | $0.00 | $0 | 271,461 | Feb 27, 2026 |
| Feb 19, 2026 | RJF RAYMOND JAMES FINANCIAL INC | AGrant or award Common Stock | +1,303 | $0.00 | $0 | 2,285 | Feb 23, 2026 |
| Feb 10, 2026 | EFX EQUIFAX INC | MOption exercise Common Stock10b5-1 | +37,791 | $112.46 | $4.2M | 236,778 | Feb 12, 2026 |
| Feb 10, 2026 | EFX EQUIFAX INC | AGrant or award Common Stock10b5-1 | +33,278 | $0.00 | $0 | 270,056 | Feb 12, 2026 |
| Feb 10, 2026 | EFX EQUIFAX INC | SOpen-market sale Common Stock10b5-1 | -201 | $197.79 | $40k | 269,855 | Feb 12, 2026 |
| Feb 10, 2026 | EFX EQUIFAX INC | SOpen-market sale Common Stock10b5-1 | -213 | $203.76 | $43k | 269,642 | Feb 12, 2026 |
| Feb 10, 2026 | EFX EQUIFAX INC | SOpen-market sale Common Stock10b5-1 | -227 | $192.89 | $44k | 269,415 | Feb 12, 2026 |
| Feb 10, 2026 | EFX EQUIFAX INC | SOpen-market sale Common Stock10b5-1 | -331 | $194.22 | $64k | 269,084 | Feb 12, 2026 |
| Feb 10, 2026 | EFX EQUIFAX INC | SOpen-market sale Common Stock10b5-1 | -364 | $195.40 | $71k | 268,720 | Feb 12, 2026 |
| Feb 10, 2026 | EFX EQUIFAX INC | SOpen-market sale Common Stock10b5-1 | -445 | $196.43 | $87k | 268,275 | Feb 12, 2026 |
| Feb 10, 2026 | EFX EQUIFAX INC | SOpen-market sale Common Stock10b5-1 | -829 | $199.00 | $165k | 267,446 | Feb 12, 2026 |
| Feb 10, 2026 | EFX EQUIFAX INC | FTax withholding Common Stock10b5-1 | -1,759 | $202.71 | $357k | 265,687 | Feb 12, 2026 |
| Feb 10, 2026 | EFX EQUIFAX INC | SOpen-market sale Common Stock10b5-1 | -1,772 | $200.03 | $354k | 263,915 | Feb 12, 2026 |
| Feb 10, 2026 | EFX EQUIFAX INC | SOpen-market sale Common Stock10b5-1 | -4,057 | $201.26 | $817k | 259,858 | Feb 12, 2026 |
| Feb 10, 2026 | EFX EQUIFAX INC | SOpen-market sale Common Stock10b5-1 | -11,000 | $203.08 | $2.2M | 248,858 | Feb 12, 2026 |
| Feb 10, 2026 | EFX EQUIFAX INC | SOpen-market sale Common Stock10b5-1 | -18,352 | $202.15 | $3.7M | 230,506 | Feb 12, 2026 |
| Feb 10, 2026 | EFX EQUIFAX INC | MOption exercise Stock Option/Right to Buyderivative10b5-1 | -37,791 | $0.00 | $0 | 113,374 | Feb 12, 2026 |
| Feb 3, 2026 | EFX EQUIFAX INC | AGrant or award Common Stock | +59,123 | $0.00 | $0 | 201,392 | Feb 5, 2026 |
| Feb 3, 2026 | EFX EQUIFAX INC | FTax withholding Common Stock | -2,405 | $175.05 | $421k | 198,987 | Feb 5, 2026 |
| Dec 31, 2025 | EFX EQUIFAX INC | FTax withholding Common Stock | -997 | $216.98 | $216k | 142,091 | Jan 5, 2026 |
| Oct 27, 2025 | EFX EQUIFAX INC | MOption exercise Common Stock10b5-1 | +27,959 | $191.44 | $5.4M | 170,940 | Oct 29, 2025 |
| Oct 27, 2025 | EFX EQUIFAX INC | GGift Common Stock10b5-1 | -47 | $0.00 | $0 | 170,893 | Oct 29, 2025 |
| Oct 27, 2025 | EFX EQUIFAX INC | SOpen-market sale Common Stock10b5-1 | -174 | $233.88 | $41k | 170,719 | Oct 29, 2025 |
| Oct 27, 2025 | EFX EQUIFAX INC | SOpen-market sale Common Stock10b5-1 | -204 | $235.22 | $48k | 170,515 | Oct 29, 2025 |
| Oct 27, 2025 | EFX EQUIFAX INC | SOpen-market sale Common Stock10b5-1 | -3,757 | $231.46 | $870k | 166,758 | Oct 29, 2025 |
| Oct 27, 2025 | EFX EQUIFAX INC | SOpen-market sale Common Stock10b5-1 | -4,015 | $233.01 | $936k | 162,743 | Oct 29, 2025 |
| Oct 27, 2025 | EFX EQUIFAX INC | SOpen-market sale Common Stock10b5-1 | -6,227 | $229.20 | $1.4M | 156,516 | Oct 29, 2025 |
| Oct 27, 2025 | EFX EQUIFAX INC | SOpen-market sale Common Stock10b5-1 | -6,639 | $230.18 | $1.5M | 149,877 | Oct 29, 2025 |
| Oct 27, 2025 | EFX EQUIFAX INC | SOpen-market sale Common Stock10b5-1 | -6,943 | $232.19 | $1.6M | 142,934 | Oct 29, 2025 |
| Oct 27, 2025 | EFX EQUIFAX INC | SOpen-market sale Common Stockindirect: 2-yr Jun 2025 GRAT10b5-1 | -37 | $233.95 | $8,656 | 43,394 | Oct 29, 2025 |
| Oct 27, 2025 | EFX EQUIFAX INC | SOpen-market sale Common Stockindirect: 2-yr Jun 2025 GRAT10b5-1 | -76 | $234.93 | $18k | 43,318 | Oct 29, 2025 |
| Oct 27, 2025 | EFX EQUIFAX INC | SOpen-market sale Common Stockindirect: 2-yr Jun 2025 GRAT10b5-1 | -2,801 | $233.12 | $653k | 40,517 | Oct 29, 2025 |
| Oct 27, 2025 | EFX EQUIFAX INC | SOpen-market sale Common Stockindirect: 2-yr Jun 2025 GRAT10b5-1 | -3,331 | $231.59 | $771k | 37,186 | Oct 29, 2025 |
| Oct 27, 2025 | EFX EQUIFAX INC | SOpen-market sale Common Stockindirect: 2-yr Jun 2025 GRAT10b5-1 | -3,995 | $229.12 | $915k | 33,191 | Oct 29, 2025 |
| Oct 27, 2025 | EFX EQUIFAX INC | SOpen-market sale Common Stockindirect: 2-yr Jun 2025 GRAT10b5-1 | -5,274 | $232.27 | $1.2M | 27,917 | Oct 29, 2025 |
| Oct 27, 2025 | EFX EQUIFAX INC | SOpen-market sale Common Stockindirect: 2-yr Jun 2025 GRAT10b5-1 | -5,872 | $230.16 | $1.4M | 22,045 | Oct 29, 2025 |
| Oct 27, 2025 | EFX EQUIFAX INC | MOption exercise Stock Option/Right to Buyderivative10b5-1 | -27,959 | $0.00 | $0 | 0 | Oct 29, 2025 |
| Jul 28, 2025 | EFX EQUIFAX INC | MOption exercise Common Stock10b5-1 | +27,960 | $191.44 | $5.4M | 191,136 | Jul 30, 2025 |
| Jul 28, 2025 | EFX EQUIFAX INC | SOpen-market sale Common Stock10b5-1 | -364 | $244.95 | $89k | 190,772 | Jul 30, 2025 |
| Jul 28, 2025 | EFX EQUIFAX INC | SOpen-market sale Common Stock10b5-1 | -831 | $243.90 | $203k | 189,941 | Jul 30, 2025 |
| Jul 28, 2025 | EFX EQUIFAX INC | SOpen-market sale Common Stock10b5-1 | -9,497 | $242.70 | $2.3M | 180,444 | Jul 30, 2025 |
| Jul 28, 2025 | EFX EQUIFAX INC | SOpen-market sale Common Stock10b5-1 | -17,731 | $241.87 | $4.3M | 162,713 | Jul 30, 2025 |
| Jul 28, 2025 | EFX EQUIFAX INC | SOpen-market sale Common Stock10b5-1 | -19,841 | $240.95 | $4.8M | 142,872 | Jul 30, 2025 |
| Jul 28, 2025 | EFX EQUIFAX INC | MOption exercise Stock Option/Right to Buyderivative10b5-1 | -27,960 | $0.00 | $0 | 27,959 | Jul 30, 2025 |
| May 21, 2025 | RJF RAYMOND JAMES FINANCIAL INC | AGrant or award Common Stock | +982 | $0.00 | $0 | 982 | May 23, 2025 |
| May 21, 2025 | NATL NCR Atleos Corp | MOption exercise Common Stock | +2,690 | $25.98 | $70k | 31,475 | May 23, 2025 |
| Apr 28, 2025 | EFX EQUIFAX INC | MOption exercise Common Stock10b5-1 | +22,160 | $175.48 | $3.9M | 164,555 | Apr 30, 2025 |
| Apr 28, 2025 | EFX EQUIFAX INC | SOpen-market sale Common Stock10b5-1 | -22,160 | $256.61 | $5.7M | 142,395 | Apr 30, 2025 |
| Apr 28, 2025 | EFX EQUIFAX INC | MOption exercise Stock Option/Right to Buyderivative10b5-1 | -22,160 | $0.00 | $0 | 0 | Apr 30, 2025 |
| Mar 31, 2025 | NATL NCR Atleos Corp | AGrant or award Phantom Stock Unitsderivative | +996 | $26.38 | $26k | 2,690 | Apr 2, 2025 |
| Feb 13, 2025 | EFX EQUIFAX INC | MOption exercise Common Stock10b5-1 | +22,161 | $175.48 | $3.9M | 164,404 | Feb 18, 2025 |
| Feb 13, 2025 | EFX EQUIFAX INC | SOpen-market sale Common Stock10b5-1 | -595 | $253.60 | $151k | 163,809 | Feb 18, 2025 |
| Feb 13, 2025 | EFX EQUIFAX INC | SOpen-market sale Common Stock10b5-1 | -1,402 | $256.31 | $359k | 162,407 | Feb 18, 2025 |
| Feb 13, 2025 | EFX EQUIFAX INC | SOpen-market sale Common Stock10b5-1 | -1,600 | $252.38 | $404k | 160,807 | Feb 18, 2025 |
| Feb 13, 2025 | EFX EQUIFAX INC | SOpen-market sale Common Stock10b5-1 | -5,214 | $255.27 | $1.3M | 155,593 | Feb 18, 2025 |
| Feb 13, 2025 | EFX EQUIFAX INC | SOpen-market sale Common Stock10b5-1 | -6,199 | $250.74 | $1.6M | 149,394 | Feb 18, 2025 |
| Feb 13, 2025 | EFX EQUIFAX INC | SOpen-market sale Common Stock10b5-1 | -7,151 | $251.60 | $1.8M | 142,243 | Feb 18, 2025 |
| Feb 13, 2025 | EFX EQUIFAX INC | MOption exercise Stock Option/Right to Buyderivative10b5-1 | -22,161 | $0.00 | $0 | 22,160 | Feb 18, 2025 |
| Feb 11, 2025 | EFX EQUIFAX INC | AGrant or award Common Stock | +20,527 | $0.00 | $0 | 143,456 | Feb 13, 2025 |
| Feb 11, 2025 | EFX EQUIFAX INC | FTax withholding Common Stock | -1,213 | $253.00 | $307k | 142,243 | Feb 13, 2025 |
| Feb 10, 2025 | EFX EQUIFAX INC | AGrant or award Common Stock | +13,524 | $0.00 | $0 | 122,929 | Feb 12, 2025 |
| Feb 10, 2025 | EFX EQUIFAX INC | AGrant or award Stock Option/Right to Buyderivative | +23,519 | $0.00 | $0 | 23,519 | Feb 12, 2025 |
| Feb 10, 2025 | EFX EQUIFAX INC | AGrant or award Stock Option/Right to Buyderivative | +21,668 | $0.00 | $0 | 21,668 | Feb 12, 2025 |
| Dec 31, 2024 | NATL NCR Atleos Corp | AGrant or award Phantom Stock Unitsderivative | +774 | $33.92 | $26k | 1,694 | Jan 3, 2025 |
| Oct 25, 2024 | EFX EQUIFAX INC | MOption exercise Common Stock10b5-1 | +58,304 | $149.53 | $8.7M | 167,487 | Oct 29, 2024 |
| Oct 25, 2024 | EFX EQUIFAX INC | SOpen-market sale Common Stock10b5-1 | -6,900 | $271.68 | $1.9M | 160,587 | Oct 29, 2024 |
| Oct 25, 2024 | EFX EQUIFAX INC | SOpen-market sale Common Stock10b5-1 | -7,703 | $272.32 | $2.1M | 152,884 | Oct 29, 2024 |
| Oct 25, 2024 | EFX EQUIFAX INC | SOpen-market sale Common Stock10b5-1 | -21,447 | $269.49 | $5.8M | 131,437 | Oct 29, 2024 |
| Oct 25, 2024 | EFX EQUIFAX INC | SOpen-market sale Common Stock10b5-1 | -22,254 | $270.45 | $6.0M | 109,183 | Oct 29, 2024 |
| Oct 25, 2024 | EFX EQUIFAX INC | MOption exercise Stock Option/Right to Buyderivative10b5-1 | -58,304 | $0.00 | $0 | 0 | Oct 29, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.